BiomX PHGE Stock
BiomX Price Chart
BiomX PHGE Financial and Trading Overview
| BiomX stock price | 0.31 USD |
| Previous Close | 0.35 USD |
| Open | 0.35 USD |
| Bid | 0.3 USD x 1100 |
| Ask | 0.49 USD x 4000 |
| Day's Range | 0.34 - 0.37 USD |
| 52 Week Range | 0.13 - 1.17 USD |
| Volume | 64.73K USD |
| Avg. Volume | 215.71K USD |
| Market Cap | 16.18M USD |
| Beta (5Y Monthly) | 1.28925 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.51 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PHGE Valuation Measures
| Enterprise Value | 1.04M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.72238195 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.042 |
Trading Information
BiomX Stock Price History
| Beta (5Y Monthly) | 1.28925 |
| 52-Week Change | -46.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 1.17 USD |
| 52 Week Low | 0.13 USD |
| 50-Day Moving Average | 0.3 USD |
| 200-Day Moving Average | 0.33 USD |
PHGE Share Statistics
| Avg. Volume (3 month) | 215.71K USD |
| Avg. Daily Volume (10-Days) | 153.26K USD |
| Shares Outstanding | 45.98M |
| Float | 28.72M |
| Short Ratio | 0.74 |
| % Held by Insiders | 14.47% |
| % Held by Institutions | 19.62% |
| Shares Short | 188.51K |
| Short % of Float | 0.42% |
| Short % of Shares Outstanding | 0.41% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -29.097% |
| Return on Equity (ttm) | -94.39% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -25049000 USD |
| Net Income Avi to Common (ttm) | -26509000 USD |
| Diluted EPS (ttm) | -0.88 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 29.35M USD |
| Total Cash Per Share (mrq) | 0.89 USD |
| Total Debt (mrq) | 18.78M USD |
| Total Debt/Equity (mrq) | 116.3 USD |
| Current Ratio (mrq) | 3.229 |
| Book Value Per Share (mrq) | 0.487 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -26774000 USD |
| Levered Free Cash Flow (ttm) | -18418750 USD |
Profile of BiomX
| Country | United States |
| State | N/A |
| City | Ness Ziona |
| Address | 22 Einstein Street |
| ZIP | 7414003 |
| Phone | 972 7 2394 2377 |
| Website | https://www.biomx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 54 |
BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC). It is developing BX004, a phage therapy for CF patients with chronic Pseudomonas aeruginosa respiratory infections that is in Phase 1b/2a clinical trials. The company's pipeline products also include BX005, a topical phage cocktail, which is in Phase 1/2 clinical study that targets Staphylococcus aureus (S. aureus), a bacteria associated with the manifestation of the disease. In addition, the company engages in the provision of colorectal cancer program that utilizes engineered phage with various payloads, which are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Q&A For BiomX Stock
What is a current PHGE stock price?
BiomX PHGE stock price today per share is 0.31 USD.
How to purchase BiomX stock?
You can buy PHGE shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for BiomX?
The stock symbol or ticker of BiomX is PHGE.
Which industry does the BiomX company belong to?
The BiomX industry is Biotechnology.
How many shares does BiomX have in circulation?
The max supply of BiomX shares is 55.5M.
What is BiomX Price to Earnings Ratio (PE Ratio)?
BiomX PE Ratio is now.
What was BiomX earnings per share over the trailing 12 months (TTM)?
BiomX EPS is -0.51 USD over the trailing 12 months.
Which sector does the BiomX company belong to?
The BiomX sector is Healthcare.